Contineum Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CTNM annual revenue was $0.0, with -100% growth year-over-year.
CTNM past revenue growth
How has CTNM's revenue growth performed historically?
Contineum Therapeutics (NASDAQ: CTNM) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Contineum Therapeutics's revenue was $0.00.
What was Contineum Therapeutics's revenue in 2024?
Contineum Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
How much does Contineum Therapeutics make in a day?
Based on Contineum Therapeutics annual revenue for the past two years, CTNM makes an average of $68,493.15 per day.
What was Contineum Therapeutics's annual revenue growth in the past year?
As of Q2 2025, Contineum Therapeutics's revenue has grown -100% year over year. This is 597.69 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Contineum Therapeutics's revenue in the past year totaled $0.00.
How much does Contineum Therapeutics make in a year?
Contineum Therapeutics's revenue by year for the past two years is:
Contineum Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
Contineum Therapeutics's annual revenue for Dec 31, 2023 was $50.00 million, a Infinity% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.